EnVVeno Medical Corporation EnVVeno Medical Corporation

EnVVeno Medical Corporation

NVNO

Peringkat dalam Saham #40242
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Harga Saham
$10.71
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$176.75K
Perubahan (1 hari)
0.79%
Perubahan (1 tahun)
169,900.00%
Negara
US
Perdagangan EnVVeno Medical Corporation (NVNO)

Kategori

Healthcare
Rasio P/E untuk EnVVeno Medical Corporation (NVNO)
Rasio P/E per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari EnVVeno Medical Corporation, rasio P/E saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki rasio P/E sebesar 0.
Riwayat rasio P/E untuk EnVVeno Medical Corporation dari 2026 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.11 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 28.94 -
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.34 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.